Literature DB >> 1395121

Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages.

A E Koch1, S L Kunkel, S W Chensue, G K Haines, R M Strieter.   

Abstract

Interleukin-1 (IL-1) has protean effects in the pathogenesis of rheumatoid arthritis (RA). These effects include production of prostaglandins and collagenase from rheumatoid fibroblasts as well as upregulation of adhesion molecule expression on these cells. IL-1 can activate monocytes and neutrophils, as well as promote the growth of fibroblasts and endothelial cells. Recently, a novel interleukin-1 receptor antagonist protein (IRAP) has been isolated, purified, cloned, and expressed, which may modulate the effects of IL-1. In this study, we present data demonstrating that macrophages isolated from human RA synovial tissues express both IL-1 and IRAP genes. In addition, RA synovial tissue macrophages and lining cells display IL-1 and IRAP antigenic expression by immunohistochemistry. In contrast, osteoarthritis synovial tissues, as compared to RA, have fewer IL-1 and IRAP-positive macrophages. Thus, the production of IL-1 balanced by IRAP may affect the joint destruction found in these diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395121     DOI: 10.1016/0090-1229(92)90243-h

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

Review 1.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

2.  Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.

Authors:  A E Koch; S L Kunkel; L A Harlow; D D Mazarakis; G K Haines; M D Burdick; R M Pope; A Walz; R M Strieter
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Adenoviral-mediated gene transfer to rabbit synovium in vivo.

Authors:  B J Roessler; E D Allen; J M Wilson; J W Hartman; B L Davidson
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  C/EBP beta regulation of the tumor necrosis factor alpha gene.

Authors:  R M Pope; A Leutz; S A Ness
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Difference in gene expression of macrophage between normal spleen and portal hypertensive spleen identified by cDNA microarray.

Authors:  Feng Yan; Xiao-Min Wang
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

6.  Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.

Authors:  A E Koch; S L Kunkel; L A Harlow; D D Mazarakis; G K Haines; M D Burdick; R M Pope; R M Strieter
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

7.  The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function.

Authors:  Bo-Chin Chiu; Christine M Freeman; Valerie R Stolberg; Jerry S Hu; Eric Komuniecki; Stephen W Chensue
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 8.  Physiologic role of interleukin-1 receptor antagonist.

Authors:  W P Arend; C Gabay
Journal:  Arthritis Res       Date:  2000-05-19

9.  Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature.

Authors:  Ajit Muley; Yoshi Odaka; Ian P Lewkowich; Shruti Vemaraju; Terry P Yamaguchi; Carrie Shawber; Belinda H Dickie; Richard A Lang
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.